CJC-1295 With DAC: Handling, Storage, and Reconstitution Guide

Sound CJC-1295 With DAC handling and storage practice keeps a lyophilized, long-acting GHRH analog intact across the long study windows it often serves. This guide covers lab best practice for storage, reconstitution for in-vitro prep, aliquoting, and record keeping. It describes lab workflows only. It is not human-use guidance.

How should CJC-1295 With DAC be handled and stored?

Keep CJC-1295 With DAC sealed, cool, dry, and shielded from light until prep. It ships as a solid, white lyophilized (freeze-dried) powder in a sealed glass vial. Its key specs are:

• Molecular formula: C165H269N47O46
• CAS number: 446262-90-4
• Molecular weight: about 3647.2 g/mol

The compound is often used in sustained-signaling designs. These are described in the CJC-1295 With DAC research applications. So stable handling across a long study window is especially important. A study that runs for days is only as reliable as the stimulus that lasts through it.

The confirmed molecular weight allows exact concentration and molar math from the vial mass. That is the base of a repeatable working stock. It is also needed to compare results across labs.

What are the recommended storage conditions for CJC-1295 With DAC?

Store the lyophilized powder at 25 degrees Celsius or below. Keep it sealed and away from heat, light, and moisture. For long storage, keep the peptide as powder and refrigerate or freeze it. Holding conditions steady through a study supports both stability and repeatable results.

• Sealed powder vial, protected from heat, light, and humidity
• Refrigerated or frozen storage for long holding periods
• Storage records kept as part of routine quality checks

The powder is more stable than material in solution. Where the design allows, keep it as powder until it is needed.

A documented cold chain helps when a result looks odd. It lets the lab trace the cause to biology rather than to a storage lapse. This is useful in the long time courses this compound supports. When a study spans days, one unrecorded temperature slip can ruin a whole study arm. Steady conditions and full records are worth the routine effort.

How is CJC-1295 With DAC reconstituted for in-vitro work?

For lab prep, the powder is typically reconstituted with bacteriostatic water or a solvent that suits the assay. Follow these steps:

• Add the solvent slowly down the vial wall, not onto the powder.
• Let it dissolve without hard shaking, which can stress the peptide in solution.
• Avoid conditions or additives that could damage the DAC group before the assay.

The maleimide-bearing DAC group is reactive by design. Reconstitution makes in-vitro working stocks. It is not an administration step.

That reactivity is exactly what gives the compound its long duration. So protecting the group during prep is key to keeping the sustained-signaling behavior the study relies on. Gentle handling and the right solvent keep the group intact. It can then bind albumin in the intended assay setting.

How should CJC-1295 With DAC aliquots and freeze-thaw cycles be managed?

After reconstitution, split the solution into single-use aliquots. This limits repeated freeze-thaw cycles, a common cause of peptide breakdown.

• Label each aliquot with compound, concentration, and date.
• Keep reconstituted material refrigerated.
• Use it within the time frame set by the lab's protocol.

The same practice appears in the CJC-1295 No DAC handling guide and the Sermorelin handling guide.

For the DAC form, single-use aliquots do a second job. They cut the number of times the reactive group faces freeze-thaw stress. This helps keep its albumin-binding ability intact across the replicates of a sustained-signaling study.

How should the CJC-1295 With DAC lot and COA be verified?

Every batch ships with a certificate of analysis (COA) checked by a third party. It documents:

• Purity by HPLC or reverse-phase chromatography
• Identity confirmed by mass spectrometry
• Lot number, testing date, and method

Record the lot in the study records, so results trace back to one batch. Sample COAs can be requested before purchase to confirm testing methods. The signaling basis these checks protect is covered in the CJC-1295 With DAC mechanism of action.

Using one verified lot through a long study removes batch variation as a confounding factor. This matters most in long designs, where small differences can build up over the time course.

Why do documentation and traceability matter?

Follow the lab's SOPs, chemical hygiene plan, and approved protocols. Wear proper PPE. Record lot numbers, storage conditions, and handling steps. Keep COAs and batch documents to support tracing and audits.

Building these records into routine bench work keeps a study repeatable and ready for audit. It avoids having to piece the record together after the fact.

A full chain from vial to result lets a sustained-signaling finding hold up under review. It also lets another lab repeat the work.

How is the reactive DAC group protected in solution?

The maleimide-bearing Drug Affinity Complex gives the compound its long duration. It is also the part most at risk during handling. Maleimide chemistry is sensitive to some conditions:

• Raised pH
• Competing thiols
• Thiol-containing buffers
• Reducing agents

Solvent and additive choices should protect the group until it is meant to bind albumin in the assay. Thiol buffers or reducing agents added before that point can quench the group. That would blunt the very sustained-signaling behavior the study aims to observe.

In practice, the DAC form calls for slightly more careful prep than a non-reactive peptide. Gentle reconstitution, a suitable solvent, and prompt aliquoting all help keep its albumin-binding ability across the replicates of a long study.

A quenched or hydrolyzed maleimide would shorten the working duration. Yet the material would look the same. Routine purity checks may not catch this failure. That is one more reason to protect the reactive group from the moment of reconstitution. Current batch documents are on the CJC-1295 With DAC product page. Keeping the reactive group intact from vial to assay is central to repeating the compound's long-duration profile.

For research use only. CJC-1295 With DAC is an investigational research peptide and is not approved for human or veterinary use. All handling described here refers to laboratory preparation for in vitro and preclinical research.